Status:
COMPLETED
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Lead Sponsor:
Stanford University
Conditions:
Spinal Cord Cancer
Brain (Nervous System) Cancers
Eligibility:
All Genders
5+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
Eligibility Criteria
Inclusion
- Intra-axial, extra-axial, or vertebral spinal lesion
- Age \> 5
- Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion
- No rapidly deteriorating symptoms of spinal cord compression
- No instability of the spine
- Life expectancy \> 6 months
Exclusion
- Patients without tumors of the spine
- Patients younger than 5 years old
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00185666
Start Date
May 1 2002
End Date
May 1 2006
Last Update
July 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305